Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?

Linskey ME.

J Neurosurg. 2008 Dec;109 Suppl:129-36. doi: 10.3171/JNS/2008/109/12/S20. Review.

PMID:
19123899
3.

Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.

Han JH, Kim DG, Chung HT, Paek SH, Jung HW.

Adv Tech Stand Neurosurg. 2016;(43):3-36. doi: 10.1007/978-3-319-21359-0_1. Review.

PMID:
26508404
4.

Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma: clinical article.

Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2013 Dec;119 Suppl:863-73.

PMID:
25077316
5.

Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.

Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2009 Oct;111(4):863-73. doi: 10.3171/2008.12.JNS08611.

PMID:
19284227
6.

Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.

Timmer FC, Hanssens PE, van Haren AE, Mulder JJ, Cremers CW, Beynon AJ, van Overbeeke JJ, Graamans K.

Laryngoscope. 2009 Jun;119(6):1076-81. doi: 10.1002/lary.20245.

PMID:
19399836
7.

Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.

Hayden Gephart MG, Hansasuta A, Balise RR, Choi C, Sakamoto GT, Venteicher AS, Soltys SG, Gibbs IC, Harsh GR, Adler JR, Chang SD.

World Neurosurg. 2013 Sep-Oct;80(3-4):359-63. doi: 10.1016/j.wneu.2012.04.001. Epub 2012 Apr 5.

PMID:
22484770
8.

Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.

Lasak JM, Klish D, Kryzer TC, Hearn C, Gorecki JP, Rine GP.

Otol Neurotol. 2008 Dec;29(8):1179-86. doi: 10.1097/MAO.0b013e31818b6639.

PMID:
18931646
9.

Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.

Paek SH, Chung HT, Jeong SS, Park CK, Kim CY, Kim JE, Kim DG, Jung HW.

Cancer. 2005 Aug 1;104(3):580-90.

10.

Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.

Collen C, Ampe B, Gevaert T, Moens M, Linthout N, De Ridder M, Verellen D, D'Haens J, Storme G.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e503-9. doi: 10.1016/j.ijrobp.2011.04.066. Epub 2011 Jun 12.

PMID:
21665381
11.

Hearing preservation after intracanalicular vestibular schwannoma radiosurgery.

Niranjan A, Mathieu D, Flickinger JC, Kondziolka D, Lunsford LD.

Neurosurgery. 2008 Dec;63(6):1054-62; discussion 1062-3. doi: 10.1227/01.NEU.0000335783.70079.85.

PMID:
19057318
12.

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.

Andrews DW, Suarez O, Goldman HW, Downes MB, Bednarz G, Corn BW, Werner-Wasik M, Rosenstock J, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1265-78.

PMID:
11483338
13.

Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.

Brown M, Ruckenstein M, Bigelow D, Judy K, Wilson V, Alonso-Basanta M, Lee JY.

Neurosurgery. 2011 Sep;69(3):605-13; discussion 613-4. doi: 10.1227/NEU.0b013e31821a42f3.

PMID:
21471832
14.

Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.

Combs SE, Welzel T, Kessel K, Habermehl D, Rieken S, Schramm O, Debus J.

Radiother Oncol. 2013 Feb;106(2):175-80. doi: 10.1016/j.radonc.2012.12.004. Epub 2013 Jan 17.

PMID:
23333012
15.

Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.

Kim YH, Kim DG, Han JH, Chung HT, Kim IK, Song SW, Park JH, Kim JW, Kim YH, Park CK, Kim CY, Paek SH, Jung HW.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):61-7. doi: 10.1016/j.ijrobp.2012.03.036. Epub 2012 May 12.

PMID:
22580122
16.

Radiation exposure of normal temporal bone structures during stereotactically guided gamma knife surgery for vestibular schwannomas.

Linskey ME, Johnstone PA, O'Leary M, Goetsch S.

J Neurosurg. 2013 Dec;119 Suppl:800-6.

PMID:
25077324
17.

Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report.

Poen JC, Golby AJ, Forster KM, Martin DP, Chinn DM, Hancock SL, Adler JR Jr.

Neurosurgery. 1999 Dec;45(6):1299-305; discussion 1305-7.

PMID:
10598696
18.

Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.

Rasmussen R, Claesson M, Stangerup SE, Roed H, Christensen IJ, CayƩ-Thomasen P, Juhler M.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e607-11. doi: 10.1016/j.ijrobp.2012.01.078. Epub 2012 May 5.

PMID:
22560549
19.

Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.

Carlson ML, Jacob JT, Pollock BE, Neff BA, Tombers NM, Driscoll CL, Link MJ.

J Neurosurg. 2013 Mar;118(3):579-87. doi: 10.3171/2012.9.JNS12919. Epub 2012 Oct 26.

PMID:
23101446
20.

Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.

Jacob JT, Carlson ML, Schiefer TK, Pollock BE, Driscoll CL, Link MJ.

Neurosurgery. 2014 May;74(5):466-74; discussion 474. doi: 10.1227/NEU.0000000000000299.

PMID:
24476904

Supplemental Content

Support Center